Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06207383

Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure

Catheter ABlation of Atrial Fibrillation Versus Atrioventricular Nodal Ablation with CondUction System Pacing in Persistent Atrial Fibrillation and Heart Failure

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
220 (estimated)
Sponsor
University Hospital, Geneva · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to evaluate two treatment strategies in patients with chronic atrial fibrillation and heart failure, who are eligible for atrial fibrillation ablation. Patients will be randomized to either atrial fibrillation ablation or to implantation of a pacemaker with conduction system pacing followed by atrioventricular node ablation. The effect of treatment allocation on total mortality, cardiovascular hospitalization and heart failure hospitalization will be compared.

Detailed description

Aim To compare clinical outcome with a strategy of conduction system pacing and atrioventricular nodal ablation (CSP+AVNA), versus atrial fibrillation (AF) ablation by pulmonary vein isolation (PVI) in patients with persistent atrial fibrillation (AF) and heart failure (HF), to guide future management of these patients. Hypotheses 1. CSP+AVNA is superior to AF ablation in patients with persistent AF and HF for reducing mortality and cardiovascular hospitalization. 2. CSP+AVNA is non-inferior to AF ablation in patients with persistent AF for reducing mortality and heart failure hospitalization. Design Investigator-initiated, prospective randomized, controlled, open-label, multicentre study conducted in \~ 30 centres from 14 countries in Europe with expertise in CSP and AF ablation. Sample size 220 patients Study duration 4 years

Conditions

Interventions

TypeNameDescription
DEVICEConduction system pacingConduction system pacing (either His bundle pacing or left bundle branch area pacing)
PROCEDUREAtrioventricular nodal ablationCatheter ablation of the atrioventricular node
PROCEDUREAtrial fibrillation ablationCatheter ablation of atrial fibrillation with pulmonary vein isolation (using technique of operator's choice, with additional lesions if deemed necessary)

Timeline

Start date
2024-10-01
Primary completion
2028-06-01
Completion
2028-12-01
First posted
2024-01-17
Last updated
2024-12-06

Locations

18 sites across 14 countries: Austria, Belgium, Bulgaria, Czechia, Finland, France, Germany, Hungary, Italy, Netherlands, Poland, Spain, Switzerland, United Kingdom

Source: ClinicalTrials.gov record NCT06207383. Inclusion in this directory is not an endorsement.